FDA Seeks Approval to Paperwork Food Trucks into Safety
Published Date: 9/25/2025
Notice
Summary
The FDA wants to make sure food trucks and shippers keep human and animal food safe during transport. They’ve sent a new info collection plan to the government for approval, aiming to keep food fresh and prevent spoilage or contamination. This affects companies moving food and might mean some paperwork, but it helps protect what we eat and when.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Transport Rules Aim to Protect Food Safety
The FDA’s proposed information collection is meant to help keep human and animal food fresh and prevent spoilage or contamination during transport. The agency says this will help protect what people and animals eat by improving sanitary transportation practices.
Food Transporters May Face New Paperwork
The FDA submitted a proposed collection of information on sanitary transportation of human and animal food to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995. If approved, companies that move food (food trucks, shippers, and carriers) may have to fill out new paperwork or keep additional records to show food stayed fresh and was not contaminated during transport.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10321 — Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.
2026-10295 — M11 Clinical Electronic Structured Harmonised Protocol (CeSHarP); International Council for Harmonisation; Guidance for Industry; Availability
The FDA just released a new, easy-to-use digital guide called M11 CeSHarP to help everyone involved in clinical trials share and review study plans faster and clearer. This affects drug companies, researchers, and regulators worldwide by setting a global standard for how trial info is written and shared electronically. The new rules kick in now, aiming to save time and reduce confusion, with no direct cost but big efficiency gains.
2026-10277 — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by July 21, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
2026-10268 — Notice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
The FDA decided not to add Hepatitis Delta Virus (HDV) to the list of tropical diseases because it doesn’t fully meet the rules about market size and who it affects. This means drug makers won’t get special priority review vouchers for HDV treatments right now. People working on HDV drugs should keep an eye out for future updates but won’t see changes or new incentives immediately.
2026-10190 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
The FDA is updating how companies ask for extra patent time when their new drugs or devices take a while to get approved. This affects drug and medical device makers who want to protect their inventions longer. Comments on these changes are open until June 22, 2026, and the update aims to keep the process clear without adding extra costs or delays.
Previous / Next Documents
Previous: 2025-18613 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act
The FDA wants to collect info about harmful stuff in tobacco products and smoke to keep people safer. Tobacco companies will need to report this info, helping the FDA track risks better. This update asks for approval to make sure the paperwork is fair and won’t cost too much time or money.
Next: 2025-18615 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Prohibited From Use in Animal Food or Feed
The FDA wants to collect info about substances that can’t be used in animal food or feed. This affects farmers, pet food makers, and anyone involved in animal feed to keep animals safe and healthy. They’re asking for approval to gather this info soon, with no big costs expected.